A detailed history of Kentucky Retirement Systems transactions in Moderna, Inc. stock. As of the latest transaction made, Kentucky Retirement Systems holds 25,125 shares of MRNA stock, worth $1.61 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
25,125
Previous 25,192 0.27%
Holding current value
$1.61 Million
Previous $2.68 Million 11.14%
% of portfolio
0.09%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$101.21 - $166.61 $6,781 - $11,162
-67 Reduced 0.27%
25,125 $2.98 Million
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $115,164 - $155,728
-1,349 Reduced 5.08%
25,192 $2.68 Million
Q4 2023

Feb 08, 2024

BUY
$69.51 - $104.43 $59,222 - $88,974
852 Added 3.32%
26,541 $2.64 Million
Q3 2023

Oct 12, 2023

SELL
$96.41 - $126.61 $64,594 - $84,828
-670 Reduced 2.54%
25,689 $2.65 Million
Q2 2023

Aug 07, 2023

BUY
$118.5 - $160.53 $27,966 - $37,885
236 Added 0.9%
26,359 $3.2 Million
Q1 2023

May 10, 2023

SELL
$135.66 - $197.02 $44,496 - $64,622
-328 Reduced 1.24%
26,123 $4.01 Million
Q4 2022

Feb 06, 2023

BUY
$118.38 - $210.04 $13,732 - $24,364
116 Added 0.44%
26,451 $4.75 Million
Q3 2022

Nov 16, 2022

BUY
$118.07 - $194.18 $76,863 - $126,411
651 Added 2.53%
26,335 $3.11 Million
Q2 2022

Aug 08, 2022

BUY
$117.13 - $176.59 $374,816 - $565,088
3,200 Added 14.23%
25,684 $3.67 Million
Q1 2022

May 09, 2022

BUY
$126.46 - $235.05 $150,866 - $280,414
1,193 Added 5.6%
22,484 $3.87 Million
Q4 2021

Feb 04, 2022

BUY
$225.82 - $368.51 $88,747 - $144,824
393 Added 1.88%
21,291 $5.41 Million
Q3 2021

Nov 17, 2021

BUY
$221.9 - $484.47 $4.64 Million - $10.1 Million
20,898 New
20,898 $8.04 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Kentucky Retirement Systems Portfolio

Follow Kentucky Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kentucky Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Kentucky Retirement Systems with notifications on news.